04.04.2025
IMV Technologies Group 法国卡苏高层人事变动
Oliver Kohlhaas接替Alain de Lambilly担任首席执行官
法国莱格勒，2025年4月3日— IMV Technologies集团宣布公司高层人事变动：自2025年4月1日起，Oliver Kohlhaas将接替Alain de Lambilly担任IMV Technologies集团首席执行官。Alain de Lambilly在过去几年中成功领导公司，现因家庭原因离职。
监事会主席Joachim Hasenmaier表示：“我们衷心感谢Alain对IMV Technologies的奉献和付出，以及他与整个IMV Technologies团队共同取得的成果和工作质量。在他的领导下，IMV Technologies在增长和转型中迈出了决定性步伐，并通过内生增长和多项战略收购巩固了市场地位。我们相信Oliver Kohlhaas将继续这一势头，并在全体IMV Technologies员工的支持下，持续推进公司战略的成功实施。”
Alain de Lambilly向IMV Technologies的客户和团队表达了感谢：“我为过去几年与客户及IMV Technologies团队共同取得的进步和成就感到自豪。我祝愿Oliver在未来取得成功，相信他将以充满感染力的热情领导公司。”
Oliver Kohlhaas分享了他的热情：“我对这一机遇感到兴奋，并将充满信心和活力地迎接这一责任。我将与IMV Technologies员工一起，继续推动公司发展，满足客户当前和未来的需求，应对不断变化的世界的挑战。”
Oliver Kohlhaas是德国人，曾在亚琛和波尔多学习数学。在战略咨询领域工作数年后，他在拜耳集团度过了20多年成功的职业生涯，先后管理法国和德国的制药业务，担任动物健康业务全球营销负责人五年，随后又负责公司战略和内部咨询五年。离开拜耳后，他创办了自己的咨询业务，之后加入IMV Technologies。
关于IMV Technologies集团
IMV Technologies是动物辅助生殖生物技术领域的全球领导者。公司成立于1963年，总部位于法国，在巴西、中国、加拿大、法国、印度、荷兰、苏格兰、西班牙、比利时、瑞典和美国设有子公司和/或生产基地。IMV Technologies在精液分析、辅助生殖、人工授精和兽医影像领域拥有领先品牌。其生命科学业务部门Cryo Bio System为人类辅助生殖和生物样本库提供设备和耗材。更多信息请访问： http://www.imv-technologies.com
Change at the top at IMV Technologies Group
Oliver Kohlhaas succeeds Alain de Lambilly as CEO
April 3rd, 2025 – L’Aigle - The IMV Technologies Group announces a change at the head of its company: as of April 1, 2025, Oliver Kohlhaas succeeds Alain de Lambilly as CEO of the IMV Technologies Group. Alain de Lambilly, who has successfully managed the company in recent years, is leaving the Group due to family reasons.
Joachim Hasenmaier, Chairman of the Supervisory Board, said: “We wholeheartedly thank Alain for his dedication and commitment to IMV Technologies and for the results and the quality of work he has accomplished together with the entire IMV Technologies organization. Under his leadership, IMV Technologies has taken decisive steps in its growth and transformation and has strengthened its position through both internal growth as well as several strategic acquisitions. We are convinced that Oliver Kohlhaas will continue this momentum, and that with the support and continued commitment of all IMV Technologies
employees, he will continue to develop and successfully implement the company's strategy.”
Alain de Lambilly shared his thanks to the IMV Technologies customers and teams for the development and transformation of the company over the past few years: “I am proud of the progress we have made with our customers and all the IMV Technologies teams and of the successes we have achieved together. I wish Oliver every success for the future, and I am convinced that he will be able to lead the company with contagious commitment.”
Oliver Kohlhaas shared his enthusiasm: “I am delighted with this opportunity and approach this responsibility with confidence and energy. Together with the IMV Technologies employees, we will continue to develop the company to serve the current and future needs of our customers and to meet the challenges of a constantly changing world.”
Oliver Kohlhaas is German. He studied mathematics in Aachen and Bordeaux. After a few years in strategy consulting, he had a successful career spanning more than 20 years with the Bayer Group. He managed pharmaceutical activities in France and Germany, spent five years as Head of Global Marketing for the animal health business, before taking charge of corporate strategy
and internal consulting for another five years. After leaving Bayer, he developed his own consulting business before joining IMVTechnologies.
About the IMV TECHNOLOGIES Group
IMV Technologies is the world leader in animal assisted reproductive biotechnologies. Founded in 1963, IMV Technologies is a French company with subsidiaries and/or production sites in Brazil, China, Canada, France, India, the Netherlands, Scotland, Spain, Belgium, Sweden and the United States. IMV Technologies operates leading brands in the fields of semen analysis, assisted reproduction, artificial insemination and veterinary imaging. IMV Technologies' Life Sciences Business Unit, Cryo Bio System, manufactures and distributes equipment and supplies for human assisted reproduction and biobanks.
For more information, please visit our website: www.imv-technologies.com